[1]
S. Lotfi, “Identification of Deferasirox as a Potential Carbonic Anhydrase II Inhibitor for Glaucoma treatment via Virtual Screening”, J Ophthalmol Opto Sci ., vol. 6, no. 1, pp. 28–41, Nov. 2023.